NCT06274541
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with a specific type of ovarian, fallopian tube, or peritoneal cancer called high grade serous or high grade endometrioid carcinoma, at any stage (I through IV)
- You are newly diagnosed, currently receiving chemotherapy (with or without surgery), in remission after finishing your first course of treatment, or being treated for the first time your cancer has come back
- A stored tissue sample (from surgery or a biopsy) taken before you received chemotherapy is available, so it can be tested for BRCA gene changes
- You are 18 years old or older
- You are able to read, understand, and sign a consent form
Who may not be able to join:
- Your cancer is a different type of ovarian, fallopian tube, or peritoneal cancer — not the high grade serous or high grade endometrioid type — or the exact type is unclear
- Your cancer has come back a second time or more
- You already know you carry a change (mutation) in the BRCA1 or BRCA2 gene
- You have already had genetic testing for BRCA1 or BRCA2 mutations, or have had a broader hereditary cancer gene panel test done
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Where this trial is recruiting
Primary endpoints
Feasibility of an upfront BRCA1/2 mutation testing pathway in HGSEC in terms of clinicians' experience.; Feasibility of an upfront BRCA1/2 mutation testing pathway in HGSEC in terms of patients' experience.; The impact on patient management by determining changes in patient treatment (use of a PARP inhibitor or enrolment in BRCA-targeted clinical trials).; The impact on patient management by use of clinical genetics counselling sessions.; The economic impact of implementing an upfront tumour BRCA1/2 mutation testing pathway in the oncology clinic for HGSEC on the Irish healthcare system, using...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.